Clinical trials / Ohio
Psychedelic and ketamine trials recruiting in Ohio
3 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Ohio on 26 Oct 2026. By substance: Psilocybin 2, Ketamine / esketamine 1. By condition: depression 3, ptsd 1.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 3Ketamine / esketamineNCT07227454
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder (AVENUE)
- Conditions:
- Depressive Disorder, Major
- Sponsor:
- Janssen Research & Development, LLC
- Who:
- ages 12 Years to 17 Years, 258 participants planned
- Also in:
- Brazil, Hungary, Italy, Romania, Spain, Taiwan
- University of Cincinnati, Cincinnati, Ohio
Phase 2PsilocybinNCT07104916
Mindfulness-based Psilocybin Therapy for PTSD
- Conditions:
- Post Traumatic Stress Disorder; Depression - Major Depressive Disorder
- Sponsor:
- Anthony P King
- Who:
- ages 21 Years to 65 Years, 30 participants planned
- The Ohio State University Medical Center, Columbus, Ohio
Phase 2PsilocybinNCT07216404
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
- Conditions:
- Lung Non-Small Cell Carcinoma; Unipolar Depression
- Sponsor:
- Alan Davis
- Who:
- ages 18 Years and over, 10 participants planned
- Ohio State University Comprehensive Cancer Center, Columbus, Ohio